Literature DB >> 21049827

Introduction: adherence to disease-modifying therapies--key to optimizing outcomes in relapsing multiple sclerosis.

Christina Caon1, Carol Saunders, Jennifer Smrtka, Karolyn Davis, Alan Davis, Jonathan M Kay, Nancy Baxter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21049827

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN： 0888-0395            Impact factor:   1.230


× No keyword cloud information.
  3 in total

1.  Walgreens connected care: impact of managed therapy on adherence to medications used to treat multiple sclerosis and related comorbid conditions.

Authors:  Janeen DuChane; Bobby Clark; Francis Staskon; Rick Miller; Kathleen Love; Ian Duncan
Journal:  Int J MS Care       Date:  2015 Mar-Apr

2.  Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis.

Authors:  Rachel Halpern; Sonalee Agarwal; Carole Dembek; Leigh Borton; Maria Lopez-Bresnahan
Journal:  Patient Prefer Adherence       Date:  2011-01-20       Impact factor: 2.711

3.  Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.

Authors:  Danny Decoo; Mathieu Vokaer
Journal:  Patient Prefer Adherence       Date:  2015-11-19       Impact factor: 2.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.